Cargando…
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica
OBJECTIVE: To minimize complement-mediated damage in acute relapses of neuromyelitis optica (NMO) by adding treatment with a complement inhibitor, purified C1-esterase inhibitor, to the current standard of care (high-dose glucocorticoids). METHOD: We conducted an open-label phase 1b safety and proof...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202676/ https://www.ncbi.nlm.nih.gov/pubmed/25340061 http://dx.doi.org/10.1212/NXI.0000000000000005 |